Skip to content

Clinical trials

Carcinoma, Medullary trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Medullary Country / region: United States Clear all

80 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20012
20021
20034
20045
20053
20067
20072
20083
20091
20103
20127
20131
20153
20161
20174
20182
20194
20203
20214
20242
20255
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed41
Active, not recruiting12
Terminated11
Recruiting5
Not yet recruiting4
Enrolling by invitation2
Approved for marketing2
Withdrawn1
No longer available1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)20
M.D. Anderson Cancer Center7
Eli Lilly and Company3
Exelixis3
Jonsson Comprehensive Cancer Center3
University of Pennsylvania3
Genzyme, a Sanofi Company2
Massachusetts General Hospital2
Novo Nordisk A/S2
Sanofi2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Medullary80
Thyroid Neoplasms32
Thyroid Cancer, Papillary18
Carcinoma, Non-Small-Cell Lung15
Head and Neck Neoplasms14
Adenocarcinoma, Follicular13
Colonic Neoplasms13
Breast Neoplasms12
Carcinoma, Hepatocellular11
Pancreatic Neoplasms11

Trials

Showing 1 to 25 of 80. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.